Eli Lilly Diabetes - Search News

Eli Lilly launches anti-obesity drug in India

Reuters on MSN · 1d

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Markets Insider · 2d

Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market

Bloomberg · 3d

Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.

12mon MSN

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Fierce Pharma2d

Lilly backs study in mission to improve Hollywood representations of obesity, diabetes, dementia and more

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results